From Risk Markers to Preventive Action: A Proposed Semi-Quantitative Clinical Actionability Framework for Cardiometabolic Precision Prevention in Primary Care—A Narrative Review
Journal of Clinical Medicine · 07.11.2026 · 15 (21) · 8706
DOI: 10.3390/jcm15218706 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 07.11.2026. Verfasst von Antoneta Dacia Petroaie und 12 weiteren Autor:innen. Beteiligte Einrichtung: "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania. Die Arbeit nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cardiometabolic prevention in primary care draws on a growing number of risk markers, yet a marker’s capacity to predict risk is often conflated with its capacity to change management. This narrative review proposes a semi-quantitative clinical actionability framework that takes the marker–context–action use case as its unit of appraisal and assigns ordinal scores (0–3) to seven domains: measurement readiness, prognostic validity, decision-relevant information, therapeutic linkage, clinical-utility evidence, harms and burden, and transportability and equity. Gating rules prevent prognostic strength alone from determining the tier. Applied by the authors to 19 use cases, the framework provisionally assigned five to Tier A (routine actionability): low-density lipoprotein cholesterol, blood pressure, type 2 diabetes detection, kidney function with albuminuria in diabetes or hypertension, and familial hypercholesterolaemia case-finding. Nine were assigned to Tier B (selective actionability), including the coronary artery calcium, apolipoprotein B, lipoprotein(a), natriuretic peptide and ankle–brachial index use cases, three to Tier C and two to Tier D. Most assignments depended on one-point differences in therapeutic linkage or clinical-utility scores. Tiers describe evaluated use cases, not intrinsic marker properties; the framework has not been validated. It implies that closing implementation gaps in Tier A use cases should generally precede the introduction of newer markers.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
ORCID-Profile: Antoneta Dacia Petroaie, Elena Teona Cosovanu, Eric Oliviu Cosovanu, Elena Popa, Luiza Simona Pohaci Antonesei
Zitieren
APA
Petroaie, A. D., Cosovanu, E. T., Cosovanu, E. O., Novac, O., Slanina, A. M., Popa, E., Bacusca, A. I., Manole, M., Ungureanu, M. I., Barbacariu, C. L., Pohaci Antonesei, L. S., Stefan, M., & Coman, E. A. (2026). From Risk Markers to Preventive Action: A Proposed Semi-Quantitative Clinical Actionability Framework for Cardiometabolic Precision Prevention in Primary Care—A Narrative Review. Journal of Clinical Medicine, 15(21), 8706. https://doi.org/10.3390/jcm15218706
Vancouver
Petroaie AD, Cosovanu ET, Cosovanu EO, Novac O, Slanina AM, Popa E, et al. From Risk Markers to Preventive Action: A Proposed Semi-Quantitative Clinical Actionability Framework for Cardiometabolic Precision Prevention in Primary Care—A Narrative Review. Journal of Clinical Medicine. 2026;15(21):8706. doi:10.3390/jcm15218706
BibTeX
@article{Petroaie2026,
author = {Petroaie, Antoneta Dacia and Cosovanu, Elena Teona and Cosovanu, Eric Oliviu and Novac, Otilia and Slanina, Ana Maria and Popa, Elena and Bacusca, Agnes Iacinta and Manole, Mihaela and Ungureanu, Monica Iuliana and Barbacariu, Carmen Liliana and Pohaci Antonesei, Luiza Simona and Stefan, Manuela and Coman, Elena Adorata},
title = {From Risk Markers to Preventive Action: A Proposed Semi-Quantitative Clinical Actionability Framework for Cardiometabolic Precision Prevention in Primary Care—A Narrative Review},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {21},
pages = {8706},
doi = {10.3390/jcm15218706}
}
EUVIMED